Paramita Chakraborty to NAD
This is a "connection" page, showing publications Paramita Chakraborty has written about NAD.
Connection Strength
0.467
-
CD38: Modulating Histone Methyltransferase EZH2 Activity in SLE. Trends Immunol. 2020 03; 41(3):187-189.
Score: 0.165
-
CD38-NAD+-Sirt1 axis in T cell immunotherapy. Aging (Albany NY). 2019 10 23; 11(20):8743-8744.
Score: 0.161
-
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018 01 09; 27(1):85-100.e8.
Score: 0.141